Cough‐Challenge Trial with a New Angiotensin‐Converting Enzyme Inhibitor, Imidapril
Authors:
- 1 May 1998
- journal article
- clinical trial
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 38 (5) , 442-446
Abstract
This study was conducted to examine whether imidaprilat, an active diacid of the angiotensin‐converting enzyme (ACE) inhibitor imidapril, preferentially inhibits angiotensin I degradation rather than bradykinin degradation, and whether imidapril is less active than other ACE inhibitors in inducing cough in patients with hypertension. The effect of imidaprilat on the inhibition of pressor response to angiotensin I and augmentation of depressor response to bradykinin was compared with that of enalaprilat and captopril in anesthetized rats. To determine the incidence of cough associated with imidapril, patients with a history of ACE inhibitor‐induced dry cough were enrolled in a randomized, open‐labeled, crossover trial with two 6‐week periods to be treated with imidapril or amlodipine, a calcium‐channel blocker. The recurrence of cough was assessed during both treatments. In the animal study, there were no significant differences in the ratio of inhibition of pressor response to angiotensin I and the augmentation of depressor response to bradykinin among the ACE inhibitors. In the cough‐challenge trial, a total of 60 patients with hypertension were enrolled in the study. Cough and cough related symptoms recurred in 98.3% of the patients (59/60) during imidapril therapy. In contrast, only two patients reported cough during treatment with amlodipine. These results indicate that imidapril has no selectivity in inhibiting angiotensin I‐ and bradykinin‐degradation in rats, and that clinically it is not different from other ACE inhibitors in inducing cough in patients with hypertension.Keywords
This publication has 10 references indexed in Scilit:
- The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureArchives of internal medicine (1960), 1997
- Guidelines for the Evaluation and Management of Heart FailureJACC, 1995
- Effects of modulators of the renin???angiotensin???aldosterone system on coughJournal Of Hypertension, 1994
- National High Blood Pressure Education Program Working Group report on hypertension in diabetes.Hypertension, 1994
- Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kininase II). Studies with bradykinin and other natural peptidesJournal of Biological Chemistry, 1993
- Cough and Angioneurotic Edema Associated with Angiotensin-Converting Enzyme Inhibitor TherapyAnnals of Internal Medicine, 1992
- The two homologous domains of human angiotensin I-converting enzyme are both catalytically activeJournal of Biological Chemistry, 1991
- Pharmacological Studies on (4S)-1-Methyl-3-{(2S)-2-[N-((1S)-1-Ethoxycarbonyl-3-Phenylpropyl)amino] Propionyl}-2-Oxolmidazolidine-4-Carboxylic Acid Hydrochloride (TA-6366), a New ACE Inhibitor: I. ACE Inhibitory and Anti-Hypertensive ActivitiesThe Japanese Journal of Pharmacology, 1990
- The Positive Association of Cough with Angiotensin‐Converting Enzyme InhibitorsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1989
- Acute and chronic effects of the angiotensin-converting enzyme inhibitor captopril in severe hypertensionThe American Journal of Cardiology, 1982